- Home
- CURV vs NBTX Comparison
CURV vs NBTX Comparison
Compare CURV & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- NBTX
- Stock Information
- Founded
- CURV 2001
- NBTX 2003
- Country
- CURV United States
- NBTX France
- Employees
- CURV N/A
- NBTX N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- CURV Consumer Discretionary
- NBTX Health Care
- Exchange
- CURV Nasdaq
- NBTX Nasdaq
- Market Cap
- CURV 248.6M
- NBTX 211.9M
- IPO Year
- CURV 2021
- NBTX 2020
- Fundamental
- Price
- CURV $2.52
- NBTX $6.67
- Analyst Decision
- CURV Hold
- NBTX Strong Buy
- Analyst Count
- CURV 4
- NBTX 1
- Target Price
- CURV $5.00
- NBTX $8.00
- AVG Volume (30 Days)
- CURV 578.3K
- NBTX 7.5K
- Earning Date
- CURV 09-03-2025
- NBTX 09-17-2025
- Dividend Yield
- CURV N/A
- NBTX N/A
- EPS Growth
- CURV N/A
- NBTX N/A
- EPS
- CURV 0.09
- NBTX N/A
- Revenue
- CURV $1,089,931,000.00
- NBTX N/A
- Revenue This Year
- CURV N/A
- NBTX N/A
- Revenue Next Year
- CURV N/A
- NBTX $74.67
- P/E Ratio
- CURV $27.62
- NBTX N/A
- Revenue Growth
- CURV N/A
- NBTX N/A
- 52 Week Low
- CURV $2.18
- NBTX $2.76
- 52 Week High
- CURV $8.39
- NBTX $7.29
- Technical
- Relative Strength Index (RSI)
- CURV 26.78
- NBTX 66.43
- Support Level
- CURV $2.42
- NBTX $6.49
- Resistance Level
- CURV $2.87
- NBTX $7.15
- Average True Range (ATR)
- CURV 0.15
- NBTX 0.36
- MACD
- CURV 0.05
- NBTX 0.11
- Stochastic Oscillator
- CURV 19.05
- NBTX 73.88
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.